Keywords: Myocardium, High-Field MRI, Stem cells, regenerative medicine
Motivation: Assessing the therapeutic integration and contractile changes using matured pluripotent stem cell-derived cardiomyocytes (PSC-CMs) for myocardial infarction (MI) remains challenging. Current limitations in in vivo evaluation slow progress in developing PSC-CM therapy to attenuate remodeling after injury.
Goal(s): To determine whether matured PSC-CMs improve ventricular function and scar integration using MRI biomarkers in a guinea pig model.
Approach: Cine and diffusion MRI measured function and structure in cell-treated versus sham-treated animals, allowing in vivo assessment of regional and global function changes.
Results: MRI revealed attenuated ventricular dilation and enhanced wall thickening in the scar region in treated animals, indicating functional integration of PSC-CMs.
Impact: This study demonstrates that MRI biomarkers can assess PSC-CM therapy efficacy in vivo, providing a tool to refine regenerative treatments. By enabling precise monitoring of therapeutic integration, this approach may guide optimization of future regenerative therapies toward clinical applications.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords